AI-generated summary
In a monkey model of Parkinson's disease induced by MPTP, the authors report that near-infrared light treatment was associated with a large reduction in astrogliosis in the substantia nigra and striatum. Its effect on microglia was more limited, with reduced cell size but no change in cell number. The study examined brain tissue from these animals, so the findings are limited to this animal model and do not establish a benefit in humans.
- Who or what was studied
- Monkeys in a subacute MPTP model of Parkinson's disease
- Limits stated in the abstract
- The study is limited to an MPTP monkey model and examined glial responses in brain tissue rather than clinical outcomes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Near-infrared. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.